Cyclist|beekeeper|Annapolitan|sailer. AdvaMed's GC & CPO, but all tweets are mine. Mostly professional, but can't resist proud dad & Wake Forest shoutouts.
It was an honor to join @CommerceGov DAS Western Hem Ian Saunders and Brazil CGU to discuss public private partnership to advance Ethical Biz Practices Across the Americas in conjunction with #Summit of Americas. @AdvaMedUpdate
Litigation Financing puts patients at risk + chills innovation--my blog describes why. We'll explore this trend in expert legal panels next week at #MedTechCon. @advamedupdate https://t.co/OiRykSooyJ
Interested in #medtech? This deserves top position on your playlist! Better yet--join our conference in LA next week and meet with medtech leaders convening with @advamedupdate https://t.co/QIvyJ6qSGx
Interested in #medtech? This deserves top position on your playlist! Better yet--join medtech leaders convening in LA next week for #MedtechCon. @AdvaMedUpdate https://t.co/QIvyJ6qSGx
ICYMI: AdvaMed's comments on third-party litigation funding were read into the record during a House Oversight Committee hearing last week. Read the full letter: https://t.co/2gSxgZPVdQ
Third-party litigation funding threatens to undermine our health care system and put patients at risk, @ChrisMedTech writes in a letter to @GOPOversight and @oversightdems. Read more from @AdvaMedUpdate’s Chief Policy Officer: https://t.co/zlPsa1Wis6
Looking forward to @PavMedInc/@LucidDiag CEO and member of the AdvaMed Board Dr. Lishan Aklog’s testimony before the House E&C health subcommittee today on the need for Congress to pass #TCET legislation. 1/
My view from the podium. Thanks @MedmarcIns for convening medtech summit & support of @AdvaMedUpdate Frivolous litigation corrodes innovation and impedes patient access to lifesaving technologies.
Thank you @MedmarcIns for long-standing support of medtech and patients everywhere. Honored to present at your medtech leadership meetings today. @AdvaMedUpdate
I'm so proud to work with leaders such as those featured here, committed to ethics, patients and medical innovation. Join us in celebrating 30 years of medtech's compass, navigating innovation for patients everywhere. @AdvaMedUpdate https://t.co/nnwvDcymVf
AdvaMed’s General Counsel and Chief Policy Officer, Chris White, explains why the Federal Trade Commission’s proposed rule on non-compete agreements could hurt patients. https://t.co/pMo0dIDMOa
#patientaccess#medtech
Thanks to my @advamedupdate colleague Ida Nassar for leading our legal policy work on FTC's overbroad noncompete rulemaking. See my blog here: FTC’s Non-Compete Agreement Rulemaking Puts Medtech Innovation and Patient Access to New Treatments at Risk https://t.co/r96hITBxf8
Great talk from Former Federal Reserve Vice Chair Roger Ferguson at the #CEOSummit this morning.
“If I were 25 and could do it over again, I would choose a career in medtech…”
.@JNJMedtech’s Ashley McEvoy has a long history of leadership in the medtech industry, and it has prepared her well to lead our AdvaMed Board as Chair. I look forward to working with her and the Board on behalf of the patients we serve. https://t.co/mPb8FkrMIE
Very cool opportunity to speak with @HamlinIsland at our CEO Summit. What an inspirational guy, on and off the field. Disciplined. Entrepreneurial. Humble. Thanks for joining us and for inspiring our entire country with your amazing recovery, Damar.
#News: Today @AdvaMedUpdate announced that Ashley McEvoy, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, was elected Chair of the AdvaMed Board of Directors. Read more: https://t.co/0p7mr7qB0I #JNJMedTechProud
Every Congress & every Administration talks about the importance of driving medical innovation & increasing patient access to care. So we created a policy blueprint to help them accomplish exactly that. Let’s get to work on this list, starting today: https://t.co/hmYh7qUSkL
@PCORI seeks members from across healthcare to fill openings on 5 advisory panels. Your perspective & leadership on patient-centered outcomes research issues can make a difference! Medtech leaders and others can learn more & apply by March 31: https://t.co/yngSqnvyPX